| Entry |
|
|---|
| Name |
Halofenate (USAN/INN) |
|---|
| Formula |
C19H17ClF3NO4
|
|---|
| Exact mass |
415.0798
|
|---|
| Mol weight |
415.79
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Efficacy |
Antihyperlipidemic, Uricosuric |
|---|
| Comment |
Clofibrate derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Hypolipidemic agent
DG01946 Hypolipidemic agent
DG01733 PPAR alpha agonist
DG01547 Fibrate
D04411 Halofenate
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C3 (PPARG)
D04411 Halofenate (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 28
1 C8y C 12.0400 -15.2600
2 C8x C 12.0400 -16.6600
3 C8x C 13.2524 -17.3600
4 C8x C 14.4649 -16.6600
5 C8y C 14.4649 -15.2600
6 C8x C 13.2524 -14.5600
7 C1d C 10.8276 -14.5600
8 O2a O 15.6960 -14.5490
9 X F 9.6151 -13.8600
10 X F 11.5757 -13.3627
11 X F 10.0921 -15.7371
12 C1c C 16.9012 -15.2447
13 C7a C 18.0835 -14.5619
14 C8y C 16.9016 -16.6596
15 C8x C 15.6658 -17.3740
16 C8x C 15.6665 -18.7740
17 C8y C 16.8793 -19.4734
18 C8x C 18.1152 -18.7590
19 C8x C 18.1144 -17.3590
20 X Cl 16.8800 -20.8600
21 O7a O 19.2775 -15.2512
22 O6a O 18.0835 -13.1602
23 C1b C 20.4654 -14.5652
24 C1b C 21.6565 -15.2529
25 N1b N 22.8459 -14.5661
26 C5a C 24.0362 -15.2534
27 C1a C 25.2261 -14.5663
28 O5a O 24.0364 -16.6598
BOND 29
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 5 8 1
9 7 9 1
10 7 10 1
11 7 11 1
12 8 12 1
13 12 13 1
14 12 14 1
15 14 15 2
16 15 16 1
17 16 17 2
18 17 18 1
19 18 19 2
20 14 19 1
21 17 20 1
22 13 21 1
23 13 22 2
24 21 23 1
25 23 24 1
26 24 25 1
27 25 26 1
28 26 27 1
29 26 28 2
|
|---|
